-
Effectiveness, safety and costs of labor induction with intravaginal misoprostol versus dinoprostone vaginal insert
Maria Asuncion Quijada Cazorla, Ana Maria Palacios Marques, Josefa Marcos Sanmartin, Eduardo Cazorla Amoros, Juan Carlos Martinez Escoriza
Research Paper: Clinical Investigation
-
Effectiveness, safety and costs of labor induction with intravaginal misoprostol versus dinoprostone vaginal insert
Maria Asuncion Quijada Cazorla, Ana Maria Palacios Marques, Josefa Marcos Sanmartin, Eduardo Cazorla Amoros, Juan Carlos Martinez Escoriza
Research Paper: Clinical Investigation
-
Effectiveness, safety and costs of labor induction with intravaginal misoprostol versus dinoprostone vaginal insert
Maria Asuncion Quijada Cazorla, Ana Maria Palacios Marques, Josefa Marcos Sanmartin, Eduardo Cazorla Amoros, Juan Carlos Martinez Escoriza
Research Paper: Clinical Investigation
-
Effectiveness, safety and costs of labor induction with intravaginal misoprostol versus dinoprostone vaginal insert
Maria Asuncion Quijada Cazorla, Ana Maria Palacios Marques, Josefa Marcos Sanmartin, Eduardo Cazorla Amoros, Juan Carlos Martinez Escoriza
Research Paper: Clinical Investigation
-
Effectiveness, safety and costs of labor induction with intravaginal misoprostol versus dinoprostone vaginal insert
Maria Asuncion Quijada Cazorla, Ana Maria Palacios Marques, Josefa Marcos Sanmartin, Eduardo Cazorla Amoros, Juan Carlos Martinez Escoriza
Research Paper: Clinical Investigation
-
Effectiveness, safety and costs of labor induction with intravaginal misoprostol versus dinoprostone vaginal insert
Maria Asuncion Quijada Cazorla, Ana Maria Palacios Marques, Josefa Marcos Sanmartin, Eduardo Cazorla Amoros, Juan Carlos Martinez Escoriza
Research Paper: Clinical Investigation
-
Challenges of combining cytotoxic chemotherapy and tyrosine kinase inhibitors
Michael P Chu, Vijaya L Damaraju & Michael B Sawyer
Perspective: Clinical Investigation
-
Challenges of combining cytotoxic chemotherapy and tyrosine kinase inhibitors
Michael P Chu, Vijaya L Damaraju & Michael B Sawyer
Perspective: Clinical Investigation
-
Challenges of combining cytotoxic chemotherapy and tyrosine kinase inhibitors
Michael P Chu, Vijaya L Damaraju & Michael B Sawyer
Perspective: Clinical Investigation
-
Challenges of combining cytotoxic chemotherapy and tyrosine kinase inhibitors
Michael P Chu, Vijaya L Damaraju & Michael B Sawyer
Perspective: Clinical Investigation
-
Challenges of combining cytotoxic chemotherapy and tyrosine kinase inhibitors
Michael P Chu, Vijaya L Damaraju & Michael B Sawyer
Perspective: Clinical Investigation
-
Challenges of combining cytotoxic chemotherapy and tyrosine kinase inhibitors
Michael P Chu, Vijaya L Damaraju & Michael B Sawyer
Perspective: Clinical Investigation
-
There should be only one priority in clinical research-to put the needs of the consumer first
Simon Denegri
Editorial: Clinical Investigation
-
There should be only one priority in clinical research-to put the needs of the consumer first
Simon Denegri
Editorial: Clinical Investigation
-
There should be only one priority in clinical research-to put the needs of the consumer first
Simon Denegri
Editorial: Clinical Investigation
-
There should be only one priority in clinical research-to put the needs of the consumer first
Simon Denegri
Editorial: Clinical Investigation
-
There should be only one priority in clinical research-to put the needs of the consumer first
Simon Denegri
Editorial: Clinical Investigation
-
There should be only one priority in clinical research-to put the needs of the consumer first
Simon Denegri
Editorial: Clinical Investigation
-
Telotristat etiprate, a novel inhibitor of serotonin synthesis for the treatment of carcinoid syndrome
Pablo Lapuerta, Brian Zambrowicz, Doug Fleming, Darren Wheeler & Arthur Sands
Special Report: Clinical Investigation
-
Telotristat etiprate, a novel inhibitor of serotonin synthesis for the treatment of carcinoid syndrome
Pablo Lapuerta, Brian Zambrowicz, Doug Fleming, Darren Wheeler & Arthur Sands
Special Report: Clinical Investigation
-
Telotristat etiprate, a novel inhibitor of serotonin synthesis for the treatment of carcinoid syndrome
Pablo Lapuerta, Brian Zambrowicz, Doug Fleming, Darren Wheeler & Arthur Sands
Special Report: Clinical Investigation
-
Telotristat etiprate, a novel inhibitor of serotonin synthesis for the treatment of carcinoid syndrome
Pablo Lapuerta, Brian Zambrowicz, Doug Fleming, Darren Wheeler & Arthur Sands
Special Report: Clinical Investigation
-
Telotristat etiprate, a novel inhibitor of serotonin synthesis for the treatment of carcinoid syndrome
Pablo Lapuerta, Brian Zambrowicz, Doug Fleming, Darren Wheeler & Arthur Sands
Special Report: Clinical Investigation
-
Telotristat etiprate, a novel inhibitor of serotonin synthesis for the treatment of carcinoid syndrome
Pablo Lapuerta, Brian Zambrowicz, Doug Fleming, Darren Wheeler & Arthur Sands
Special Report: Clinical Investigation
-
Considerations in the design of clinical trials for multibacillary leprosy treatment
Maria Lucia Fernandes Penna
Clinical Trail Perspective: Clinical Investigation
-
Considerations in the design of clinical trials for multibacillary leprosy treatment
Maria Lucia Fernandes Penna
Clinical Trail Perspective: Clinical Investigation
-
Considerations in the design of clinical trials for multibacillary leprosy treatment
Maria Lucia Fernandes Penna
Clinical Trail Perspective: Clinical Investigation
-
Considerations in the design of clinical trials for multibacillary leprosy treatment
Maria Lucia Fernandes Penna
Clinical Trail Perspective: Clinical Investigation
-
Considerations in the design of clinical trials for multibacillary leprosy treatment
Maria Lucia Fernandes Penna
Clinical Trail Perspective: Clinical Investigation
-
Considerations in the design of clinical trials for multibacillary leprosy treatment
Maria Lucia Fernandes Penna
Clinical Trail Perspective: Clinical Investigation
-
New evidence supports tandem treatment in some ovarian cancers
News and Views: Clinical Investigation
-
New evidence supports tandem treatment in some ovarian cancers
News and Views: Clinical Investigation
-
New evidence supports tandem treatment in some ovarian cancers
News and Views: Clinical Investigation
-
New evidence supports tandem treatment in some ovarian cancers
News and Views: Clinical Investigation
-
New evidence supports tandem treatment in some ovarian cancers
News and Views: Clinical Investigation
-
New evidence supports tandem treatment in some ovarian cancers
News and Views: Clinical Investigation
-
Treatment of high-risk neuroblastoma in children: recent clinic trial results
Emily Greengard,Christine Hill-Kayser,Rochelle Bagatell
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of high-risk neuroblastoma in children: recent clinic trial results
Emily Greengard,Christine Hill-Kayser,Rochelle Bagatell
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of high-risk neuroblastoma in children: recent clinic trial results
Emily Greengard,Christine Hill-Kayser,Rochelle Bagatell
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of high-risk neuroblastoma in children: recent clinic trial results
Emily Greengard,Christine Hill-Kayser,Rochelle Bagatell
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of high-risk neuroblastoma in children: recent clinic trial results
Emily Greengard,Christine Hill-Kayser,Rochelle Bagatell
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of high-risk neuroblastoma in children: recent clinic trial results
Emily Greengard,Christine Hill-Kayser,Rochelle Bagatell
Review: Clinical Trail Outcomes: Clinical Investigation
-
Rethinking Phase II clinical trial design in heart failure
Kory J Lavine , Douglas L Mann
Clinical Trail Methodology: Clinical Investigation
-
Rethinking Phase II clinical trial design in heart failure
Kory J Lavine , Douglas L Mann
Clinical Trail Methodology: Clinical Investigation
-
Rethinking Phase II clinical trial design in heart failure
Kory J Lavine , Douglas L Mann
Clinical Trail Methodology: Clinical Investigation
-
Rethinking Phase II clinical trial design in heart failure
Kory J Lavine , Douglas L Mann
Clinical Trail Methodology: Clinical Investigation
-
Rethinking Phase II clinical trial design in heart failure
Kory J Lavine , Douglas L Mann
Clinical Trail Methodology: Clinical Investigation
-
Rethinking Phase II clinical trial design in heart failure
Kory J Lavine , Douglas L Mann
Clinical Trail Methodology: Clinical Investigation
-
Approaches to the design of clinical trials for primary sclerosing cholangitis*** Design of clinical trials for primary sclerosing cholangitis
Mohamad H Imam, Keith D Lindor, Jayant A Talwalkar
Clinical Trail Methodology: Clinical Investigation
-
Approaches to the design of clinical trials for primary sclerosing cholangitis*** Design of clinical trials for primary sclerosing cholangitis
Mohamad H Imam, Keith D Lindor, Jayant A Talwalkar
Clinical Trail Methodology: Clinical Investigation
-
Approaches to the design of clinical trials for primary sclerosing cholangitis*** Design of clinical trials for primary sclerosing cholangitis
Mohamad H Imam, Keith D Lindor, Jayant A Talwalkar
Clinical Trail Methodology: Clinical Investigation
-
Approaches to the design of clinical trials for primary sclerosing cholangitis*** Design of clinical trials for primary sclerosing cholangitis
Mohamad H Imam, Keith D Lindor, Jayant A Talwalkar
Clinical Trail Methodology: Clinical Investigation
-
Approaches to the design of clinical trials for primary sclerosing cholangitis*** Design of clinical trials for primary sclerosing cholangitis
Mohamad H Imam, Keith D Lindor, Jayant A Talwalkar
Clinical Trail Methodology: Clinical Investigation
-
Approaches to the design of clinical trials for primary sclerosing cholangitis*** Design of clinical trials for primary sclerosing cholangitis
Mohamad H Imam, Keith D Lindor, Jayant A Talwalkar
Clinical Trail Methodology: Clinical Investigation
-
Clinical evidence of the role of edoxaban in anticoagulation
Elena Fortuny ,Jose Zamorano
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence of the role of edoxaban in anticoagulation
Elena Fortuny ,Jose Zamorano
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence of the role of edoxaban in anticoagulation
Elena Fortuny ,Jose Zamorano
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence of the role of edoxaban in anticoagulation
Elena Fortuny ,Jose Zamorano
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence of the role of edoxaban in anticoagulation
Elena Fortuny ,Jose Zamorano
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence of the role of edoxaban in anticoagulation
Elena Fortuny ,Jose Zamorano
Review: Clinical Trail Outcomes: Clinical Investigation
-
US FDA approves trastuzumab for the treatment of HER2-positive metastatic stomach cancer
News and Views: Clinical Investigation
-
US FDA approves trastuzumab for the treatment of HER2-positive metastatic stomach cancer
News and Views: Clinical Investigation
-
US FDA approves trastuzumab for the treatment of HER2-positive metastatic stomach cancer
News and Views: Clinical Investigation
-
US FDA approves trastuzumab for the treatment of HER2-positive metastatic stomach cancer
News and Views: Clinical Investigation
-
US FDA approves trastuzumab for the treatment of HER2-positive metastatic stomach cancer
News and Views: Clinical Investigation
-
US FDA approves trastuzumab for the treatment of HER2-positive metastatic stomach cancer
News and Views: Clinical Investigation
-
From no to yes: the history and ethics of including pregnant women in clinical trials
David M Haas
Editorial: Clinical Investigation
-
From no to yes: the history and ethics of including pregnant women in clinical trials
David M Haas
Editorial: Clinical Investigation
-
From no to yes: the history and ethics of including pregnant women in clinical trials
David M Haas
Editorial: Clinical Investigation
-
From no to yes: the history and ethics of including pregnant women in clinical trials
David M Haas
Editorial: Clinical Investigation
-
From no to yes: the history and ethics of including pregnant women in clinical trials
David M Haas
Editorial: Clinical Investigation
-
From no to yes: the history and ethics of including pregnant women in clinical trials
David M Haas
Editorial: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Mark Leuchtenberger and Scott Hopkins
Leuchtenberger, Scott Hopkins
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Mark Leuchtenberger and Scott Hopkins
Leuchtenberger, Scott Hopkins
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Mark Leuchtenberger and Scott Hopkins
Leuchtenberger, Scott Hopkins
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Mark Leuchtenberger and Scott Hopkins
Leuchtenberger, Scott Hopkins
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Mark Leuchtenberger and Scott Hopkins
Leuchtenberger, Scott Hopkins
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Mark Leuchtenberger and Scott Hopkins
Leuchtenberger, Scott Hopkins
Interview: Clinical Investigation
-
New approaches to the design of sublingual immunotherapy clinical trials
Enrico Compalati, Anthi Rogkakou, Alberto Bordo, Giorgio Walter Canonica, Giovanni Passalacqua
Review Article: Clinical Investigation
-
New approaches to the design of sublingual immunotherapy clinical trials
Enrico Compalati, Anthi Rogkakou, Alberto Bordo, Giorgio Walter Canonica, Giovanni Passalacqua
Review Article: Clinical Investigation
-
New approaches to the design of sublingual immunotherapy clinical trials
Enrico Compalati, Anthi Rogkakou, Alberto Bordo, Giorgio Walter Canonica, Giovanni Passalacqua
Review Article: Clinical Investigation
-
New approaches to the design of sublingual immunotherapy clinical trials
Enrico Compalati, Anthi Rogkakou, Alberto Bordo, Giorgio Walter Canonica, Giovanni Passalacqua
Review Article: Clinical Investigation
-
New approaches to the design of sublingual immunotherapy clinical trials
Enrico Compalati, Anthi Rogkakou, Alberto Bordo, Giorgio Walter Canonica, Giovanni Passalacqua
Review Article: Clinical Investigation
-
New approaches to the design of sublingual immunotherapy clinical trials
Enrico Compalati, Anthi Rogkakou, Alberto Bordo, Giorgio Walter Canonica, Giovanni Passalacqua
Review Article: Clinical Investigation
-
An approach to personalized medicine: the BATTLE trial
Niels Reinmuth, Michael Thomas
Review Article: Clinical Investigation
-
An approach to personalized medicine: the BATTLE trial
Niels Reinmuth, Michael Thomas
Review Article: Clinical Investigation
-
An approach to personalized medicine: the BATTLE trial
Niels Reinmuth, Michael Thomas
Review Article: Clinical Investigation
-
An approach to personalized medicine: the BATTLE trial
Niels Reinmuth, Michael Thomas
Review Article: Clinical Investigation
-
An approach to personalized medicine: the BATTLE trial
Niels Reinmuth, Michael Thomas
Review Article: Clinical Investigation
-
An approach to personalized medicine: the BATTLE trial
Niels Reinmuth, Michael Thomas
Review Article: Clinical Investigation